Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bold

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Cancer Letters|November 4, 2018
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse modelsMei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, et al.
Cancer|January 28, 1999
Patterns of recurrence in extremity liposarcoma: implications for staging and follow-upD B Pearlstone, P W Pisters, R J Bold, et al.
Iscience|March 27, 2024
Whole-genome bisulfite sequencing identifies stage- and subtype-specific DNA methylation signatures in pancreatic cancerSarah S Wang, Madison L Hall, EunJung Lee, et al.
Annals of Surgical Oncology|December 30, 1998
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]M Bouvet, R J Bold, J Lee, et al.
Cancer Research|January 17, 2009
Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosisRandie H Kim, Jodi M Coates, Tawnya L Bowles, et al.
Annals of Surgical Oncology|June 10, 2020
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
Annals of Surgical Oncology|July 13, 2019
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
Frontiers in Oncology|May 7, 2020
The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case ReportSean J Judge, Jingran Ji, James Liu, et al.
Annals of Surgical Oncology|May 2, 2026
Do Postoperative Complications Impact Adjuvant Chemotherapy in Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?Dillon C Cheung, Stephanie Yu, Chee-Chee Stucky, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 11, 1999
Prognostic factors in resectable pancreatic cancer: p53 and bcl-2R J Bold, K R Hess, A S Pearson, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Cancer Letters|November 4, 2018
Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse modelsMei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, et al.
Cancer|January 28, 1999
Patterns of recurrence in extremity liposarcoma: implications for staging and follow-upD B Pearlstone, P W Pisters, R J Bold, et al.
Iscience|March 27, 2024
Whole-genome bisulfite sequencing identifies stage- and subtype-specific DNA methylation signatures in pancreatic cancerSarah S Wang, Madison L Hall, EunJung Lee, et al.
Annals of Surgical Oncology|December 30, 1998
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]M Bouvet, R J Bold, J Lee, et al.
Cancer Research|January 17, 2009
Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosisRandie H Kim, Jodi M Coates, Tawnya L Bowles, et al.
Annals of Surgical Oncology|June 10, 2020
Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
Annals of Surgical Oncology|July 13, 2019
SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast CancerMichael D Alvarado, Elizabeth A Mittendorf, Mediget Teshome, et al.
Frontiers in Oncology|May 7, 2020
The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case ReportSean J Judge, Jingran Ji, James Liu, et al.
Annals of Surgical Oncology|May 2, 2026
Do Postoperative Complications Impact Adjuvant Chemotherapy in Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?Dillon C Cheung, Stephanie Yu, Chee-Chee Stucky, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 11, 1999
Prognostic factors in resectable pancreatic cancer: p53 and bcl-2R J Bold, K R Hess, A S Pearson, et al.
Pageof 19